Abstract | BACKGROUND: METHODS AND RESULTS:
RPR101511A is a novel compound which selectively and potently inhibits the cell-free and in situ PDGFr-TK and PDGFr-dependent proliferation and chemotaxis in vascular smooth muscle cells (VSMC). To evaluate the effect of RPR101511A (30 mg. kg-1. d-1 BID for 28 days following PTCA) on coronary restenosis, PTCA was performed in hypercholesterolemic minipigs whose left anterior descending (LAD) coronary artery had been injured by overdilation and denudation, yielding a previously existing lesion. Angiographically determined prePTCA minimal lumen diameters (MLD) were similar in vehicle and RPR101511A-treated pigs (1.98+/-0.09 versus 2.01+/-0.08 mm) and increased to the same extent in the 2 groups following successful PTCA (2.30+/-0.06 versus 2.52+/-0.13). At termination, there was an average 50% loss of gain in the vehicle-treated group but no loss of gain with RPR101511A (2.16+/-0. 05 versus 2.59+/-0.11, P<0.001). Morphometric analysis of the LAD showed that RPR101511A caused a significant decrease in total intimal/medial ratio (0.96+/-0.58 versus 0.67+/-0.09, P<0.05). CONCLUSIONS:
RPR101511A, which acts by inhibition of the PDGFr-TK, completely prevented angiographic loss of gain following PTCA and significantly reduced histological intimal hyperplasia.
|
Authors | G Bilder, T Wentz, R Leadley, D Amin, L Byan, B O'Conner, S Needle, H Galczenski, J Bostwick, C Kasiewski, M Myers, A Spada, L Merkel, C Ly, P Persons, K Page, M Perrone, C Dunwiddie |
Journal | Circulation
(Circulation)
Vol. 99
Issue 25
Pg. 3292-9
(Jun 29 1999)
ISSN: 1524-4539 [Electronic] United States |
PMID | 10385505
(Publication Type: Journal Article)
|
Chemical References |
- Enzyme Inhibitors
- Quinoxalines
- RPR 101511A
- Thiophenes
- Protein-Tyrosine Kinases
- Receptors, Platelet-Derived Growth Factor
|
Topics |
- Administration, Oral
- Angioplasty, Balloon, Coronary
- Animals
- Coronary Disease
(prevention & control, therapy)
- Enzyme Inhibitors
(pharmacology)
- Protein-Tyrosine Kinases
(antagonists & inhibitors)
- Quinoxalines
(pharmacology)
- Receptors, Platelet-Derived Growth Factor
(metabolism)
- Recurrence
- Swine
- Thiophenes
(pharmacology)
- Time Factors
- Tunica Intima
(metabolism)
- Tunica Media
(metabolism)
|